415 related articles for article (PubMed ID: 26434988)
1. Role of Vasodilator Testing in Pulmonary Hypertension.
Sharma A; Obiagwu C; Mezue K; Garg A; Mukherjee D; Haythe J; Shetty V; Einstein AJ
Prog Cardiovasc Dis; 2016; 58(4):425-33. PubMed ID: 26434988
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension.
Tonelli AR; Alnuaimat H; Mubarak K
Respir Med; 2010 Apr; 104(4):481-96. PubMed ID: 20004088
[TBL] [Abstract][Full Text] [Related]
3. Inhaled Therapies for Pulmonary Hypertension.
Hill NS; Preston IR; Roberts KE
Respir Care; 2015 Jun; 60(6):794-802; discussion 802-5. PubMed ID: 26070575
[TBL] [Abstract][Full Text] [Related]
4. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
5. Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension.
Jing ZC; Jiang X; Han ZY; Xu XQ; Wang Y; Wu Y; Lv H; Ma CR; Yang YJ; Pu JL
Eur Respir J; 2009 Jun; 33(6):1354-60. PubMed ID: 19213781
[TBL] [Abstract][Full Text] [Related]
6. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
8. Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.
Petkov V; Ziesche R; Mosgoeller W; Schenk P; Vonbank K; Stiebellehner L; Raderer M; Brunner C; Kneussl M; Block LH
Thorax; 2001 Sep; 56(9):734-6. PubMed ID: 11514696
[TBL] [Abstract][Full Text] [Related]
9. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary hypertension: the issues of diagnosis and treatment].
Sakalauskas R; Barkauskiene D; Vebriene J; Sadauskas S
Medicina (Kaunas); 2004; 40(10):1019-25. PubMed ID: 15516828
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
Tian Z; Chen TB; Fang Q; Zeng XF; Liu YT; Li MT; Jiang XC; Gao P; Cheng KA; Wang Q
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2099-102. PubMed ID: 20058611
[TBL] [Abstract][Full Text] [Related]
12. [How to do vasoreactivity test?].
Canpolat U; Kaya EB
Turk Kardiyol Dern Ars; 2012 Jun; 40(4):386-9. PubMed ID: 22951858
[No Abstract] [Full Text] [Related]
13. Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension.
Bourge RC; Tapson VF; Safdar Z; Benza RL; Channick RN; Rosenzweig EB; Shapiro S; White RJ; McSwain CS; Gotzkowsky SK; Nelsen AC; Rubin LJ
Cardiovasc Ther; 2013 Feb; 31(1):38-44. PubMed ID: 22970909
[TBL] [Abstract][Full Text] [Related]
14. Acute hemodynamic effects of intravenous adenosine in patients with associated pulmonary arterial hypertension: Comparison with intravenous epoprostenol.
Rossi R; Coppi F; Sgura F; Monopoli D; Boriani G
Pulm Pharmacol Ther; 2018 Apr; 49():147-151. PubMed ID: 28642014
[TBL] [Abstract][Full Text] [Related]
15. Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan.
Beghetti M
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():16-24. PubMed ID: 16919006
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic management of primary pulmonary hypertension].
Chaouat A; Weitzenblum E
Presse Med; 2002 Feb; 31(7):320-8. PubMed ID: 11899690
[TBL] [Abstract][Full Text] [Related]
17. Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer?
Opitz CF; Rubin LJ
Eur Respir J; 2009 Jun; 33(6):1247-9. PubMed ID: 19483043
[No Abstract] [Full Text] [Related]
18. Acute vasoreactivity testing with nicardipine in patients with pulmonary arterial hypertension.
Saito Y; Nakamura K; Miyaji K; Akagi S; Mizoguchi H; Ogawa A; Fuke S; Fujio H; Kiyooka T; Nagase S; Kohno K; Morita H; Kusano KF; Matsubara H; Ohe T; Ito H
J Pharmacol Sci; 2012; 120(3):206-12. PubMed ID: 23117888
[TBL] [Abstract][Full Text] [Related]
19. Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties.
Ulrich S; Fischler M; Speich R; Popov V; Maggiorini M
Chest; 2006 Sep; 130(3):841-6. PubMed ID: 16963684
[TBL] [Abstract][Full Text] [Related]
20. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]